Metastasis: the seed and soil theory gains identity

The metastatic spread of tumor cells to distant sites represents the major cause of cancer-related deaths. Cancer metastasis involves a series of complex interactions between tumor cells and microenvironment that influence its biological effectiveness and facilitate tumor cell arrest to distant organs. More than a century since Paget developed the theory of seed and soil, the enigma of tissue specificity observed in metastatic colonization of tumor cells begins to unfold itself. The advent of new technologies has led to the discovery of novel molecules and pathways that confer metastasis-associated properties to the cancer cells, mediating organ specificity and unique genetic signatures have been developed using microarray studies. Future clinical studies and new antimetastatic compounds aiming to improve survival of patients with metastasis will most probably be based on these signatures. This review summarizes the plethora of old and new molecules that are strongly correlated with organ-specific metastases and which provide now an identity to the theory of seed and soil.

[1]  Kerstin Lang,et al.  Tumour-cell migration, invasion, and metastasis: navigation by neurotransmitters. , 2004, The Lancet. Oncology.

[2]  Xin Wei Wang,et al.  Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. , 2006, Cancer cell.

[3]  S. Mohan,et al.  Osteogenic Protein-1 Stimulates mRNA Levels of BMP-6 and Decreases mRNA Levels of BMP-2 and -4 in Human Osteosarcoma Cells , 1997, Calcified Tissue International.

[4]  D. Mukhopadhyay,et al.  Effect of Rapamycin Alone and in Combination with Antiangiogenesis Therapy in an Orthotopic Model of Human Pancreatic Cancer , 2004, Clinical Cancer Research.

[5]  J. Chirgwin,et al.  Basic Mechanisms Responsible for Osteolytic and Osteoblastic Bone Metastases , 2006, Clinical Cancer Research.

[6]  Z. Werb,et al.  New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.

[7]  Q. Zeng,et al.  Generation of PRL-3- and PRL-1-Specific Monoclonal Antibodies as Potential Diagnostic Markers for Cancer Metastases , 2005, Clinical Cancer Research.

[8]  L. Qin,et al.  Overexpression of Platelet-Derived Growth Factor Receptor α in Endothelial Cells of Hepatocellular Carcinoma Associated with High Metastatic Potential , 2005, Clinical Cancer Research.

[9]  G. Mundy Endothelin-1 and osteoblastic metastasis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[10]  E. Ruoslahti,et al.  Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. , 2004, Cancer cell.

[11]  Li Mao,et al.  Global expression-based classification of lymph node metastasis and extracapsular spread of oral tongue squamous cell carcinoma. , 2006, Neoplasia.

[12]  J. Conroy,et al.  Prostate-Specific Antigen Modulates Genes Involved in Bone Remodeling and Induces Osteoblast Differentiation of Human Osteosarcoma Cell Line SaOS-2 , 2006, Clinical Cancer Research.

[13]  G. Mundy Metastasis: Metastasis to bone: causes, consequences and therapeutic opportunities , 2002, Nature Reviews Cancer.

[14]  J. H. Lee,et al.  Suppression of metastasis in human breast carcinoma MDA-MB-435 cells after transfection with the metastasis suppressor gene, KiSS-1. , 1997, Cancer research.

[15]  C. Bucana,et al.  Inhibition of platelet-derived growth factor receptor phosphorylation by STI571 (Gleevec) reduces growth and metastasis of human pancreatic carcinoma in an orthotopic nude mouse model. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[16]  Rebecca Aucoin,et al.  Brain metastases in melanoma: roles of neurotrophins. , 2004, Neuro-oncology.

[17]  D. Peehl,et al.  CXCR4 and CXCL12 (SDF-1) in Prostate Cancer , 2004, Clinical Cancer Research.

[18]  Andy J. Minn,et al.  Genes that mediate breast cancer metastasis to lung , 2005, Nature.

[19]  P. Steeg Metastasis suppressors alter the signal transduction of cancer cells , 2003, Nature Reviews Cancer.

[20]  S. Mukherji,et al.  Cervical nodal metastases in squamous cell carcinoma of the head and neck: What to expect , 2001, Head & neck.

[21]  E. Kleinerman,et al.  Osterix, a transcription factor for osteoblast differentiation, mediates antitumor activity in murine osteosarcoma. , 2005, Cancer research.

[22]  L. Ellis,et al.  Expression of vascular endothelial growth factor is necessary but not sufficient for production and growth of brain metastasis. , 2000, Cancer research.

[23]  J. Li,et al.  Astrocytes contribute to the brain-metastatic specificity of melanoma cells by producing heparanase. , 2000, Cancer research.

[24]  S. Steinberg,et al.  Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain. , 2007, Cancer research.

[25]  Bingham Ja Letter: Lower oesophageal sphincter. , 1974 .

[26]  M. Kasuga,et al.  High Expression of PRL-3 Promotes Cancer Cell Motility and Liver Metastasis in Human Colorectal Cancer , 2004, Clinical Cancer Research.

[27]  K. Miura,et al.  Interaction of KAI1 on tumor cells with DARC on vascular endothelium leads to metastasis suppression , 2006, Nature Medicine.

[28]  O. S. Nielsen,et al.  Bone metastases: pathophysiology and management policy. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  J M Trent,et al.  KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. , 1996, Journal of the National Cancer Institute.

[30]  G. Nicolson,et al.  Neurotrophin stimulation of human melanoma cell invasion: selected enhancement of heparanase activity and heparanase degradation of specific heparan sulfate subpopulations. , 1996, Cancer research.

[31]  J. Myers,et al.  Extent of extracapsular spread , 2003, Cancer.

[32]  Jian Hui Wu,et al.  Differential metastasis-associated gene analysis of prostate carcinoma cells derived from primary tumor and spontaneous lymphatic metastasis in nude mice with orthotopic implantation of PC-3M cells. , 2006, Cancer letters.

[33]  G. Roodman Mechanisms of bone metastasis. , 2004, Discovery medicine.

[34]  A. Iwamatsu,et al.  Activation of ErbB3–PI3-kinase pathway is correlated with malignant phenotypes of adenocarcinomas , 2003, Oncogene.

[35]  M. Mehta,et al.  Current management of brain metastases, with a focus on systemic options. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  A. Pappo,et al.  Brain metastases in children with melanoma , 1997, Cancer.

[37]  I. Fidler,et al.  Critical determinants of metastasis. , 2002, Seminars in cancer biology.

[38]  Suyun Huang,et al.  Vascular endothelial growth factor expression promotes the growth of breast cancer brain metastases in nude mice , 2004, Clinical & Experimental Metastasis.

[39]  P. Kostenuik,et al.  Osteoprotegerin inhibits osteolysis and decreases skeletal tumor burden in syngeneic and nude mouse models of experimental bone metastasis. , 2001, Cancer research.

[40]  W. Dougall,et al.  The RANK/RANKL/OPG triad in cancer-induced bone diseases , 2007, Cancer and Metastasis Reviews.

[41]  Hans Clevers,et al.  Wnt/β-Catenin Signaling in Development and Disease , 2006, Cell.

[42]  Philip Lijnzaad,et al.  An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas , 2005, Nature Genetics.

[43]  F. Bérard,et al.  A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype. , 2000, Cancer research.

[44]  D. L. Kinsey An experimental study of preferential metastasis , 1960, Cancer.

[45]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[46]  A. Dachman,et al.  Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[47]  J. Nelson,et al.  Identification of endothelin–1 in the pathophysiology of metastatic adenocarcinoma of the prostate , 1995, Nature Medicine.

[48]  A. Cox,et al.  PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility. , 2006, Cancer research.

[49]  K. Kim,et al.  KAI1 COOH-Terminal Interacting Tetraspanin (KITENIN), a Member of the Tetraspanin Family, Interacts with KAI1, a Tumor Metastasis Suppressor, and Enhances Metastasis of Cancer , 2004, Cancer Research.

[50]  Yusuke Nakamura,et al.  Expression profiles of non-small cell lung cancers on cDNA microarrays: Identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs , 2003, Oncogene.

[51]  W. Dougall,et al.  Soluble receptor activator of nuclear factor kappaB Fc diminishes prostate cancer progression in bone. , 2003, Cancer research.

[52]  A. Ryan,et al.  Inhibition of Src Tyrosine Kinase as Treatment for Human Pancreatic Cancer Growing Orthotopically in Nude Mice , 2004, Clinical Cancer Research.

[53]  G. Stein,et al.  Osteoblast-related transcription factors Runx2 (Cbfa1/AML3) and MSX2 mediate the expression of bone sialoprotein in human metastatic breast cancer cells. , 2003, Cancer research.

[54]  M. Seibel,et al.  Mechanisms of Disease: roles of OPG, RANKL and RANK in the pathophysiology of skeletal metastasis , 2006, Nature Clinical Practice Oncology.

[55]  Stephen M Hewitt,et al.  The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis , 2004, Nature Medicine.

[56]  G. Stein,et al.  Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone , 2006, Cancer and Metastasis Reviews.

[57]  D. Huylebroeck,et al.  Follistatins neutralize activin bioactivity by inhibition of activin binding to its type II receptors , 1996, Molecular and Cellular Endocrinology.

[58]  J. Deng,et al.  The Novel Zinc Finger-Containing Transcription Factor Osterix Is Required for Osteoblast Differentiation and Bone Formation , 2002, Cell.

[59]  S. Goodison,et al.  The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells. , 2005, Cancer research.

[60]  I. Fidler,et al.  The organ microenvironment and cancer metastasis. , 2002, Differentiation; research in biological diversity.

[61]  S. Powers,et al.  Metastatic properties and genomic amplification of the tyrosine kinase gene ACK1. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[62]  Michiie Sakamoto,et al.  Growth and spread of hepatocellular carcinoma: A review of 240 consecutive autopsy cases , 1990, Cancer.

[63]  Abraham Schneider,et al.  Skeletal Localization and Neutralization of the SDF‐1(CXCL12)/CXCR4 Axis Blocks Prostate Cancer Metastasis and Growth in Osseous Sites In Vivo , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[64]  J. Li,et al.  PRL-3 and PRL-1 promote cell migration, invasion, and metastasis. , 2003, Cancer research.

[65]  O. Kozawa,et al.  Endothelin-1 induces vascular endothelial growth factor synthesis in osteoblasts: involvement of p38 mitogen-activated protein kinase. , 2000, Cellular signalling.

[66]  J. Price,et al.  Astrocyte-derived cytokines contribute to the metastatic brain specificity of breast cancer cells. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[67]  P. Steeg Perspectives on classic article: metastasis suppressor genes. , 2004, Journal of the National Cancer Institute.

[68]  X. Wang,et al.  Predicting hepatitis B virus–positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning , 2003, Nature Medicine.

[69]  L. Ellis,et al.  Surgical resection after downsizing of colorectal liver metastasis in the era of bevacizumab. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[70]  R. Scolyer,et al.  Cytoplasmic expression of nm23 predicts the potential for cerebral metastasis in patients with primary cutaneous melanoma , 2004, Melanoma research.

[71]  E. Sugarbaker The organ selectivity of experimentally induced metastases in rats , 1952, Cancer.

[72]  J. Hecht,et al.  Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: results of a randomized phase II trial. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[73]  A. Ochiai,et al.  Prostate‐specific antigen induces apoptosis of osteoclast precursors: Potential Role in osteoblastic bone metastases of prostate cancer , 2006, The Prostate.

[74]  D. Brigstock,et al.  Connective tissue growth factor: what's in a name? , 2000, Molecular genetics and metabolism.

[75]  L. Chung,et al.  Osteomimetic properties of prostate cancer cells: A hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment , 1999, The Prostate.

[76]  A. Potti,et al.  Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications. , 2004, Cancer.

[77]  Patrick Kemmeren,et al.  Multiple robust signatures for detecting lymph node metastasis in head and neck cancer. , 2006, Cancer research.

[78]  C. Cordon-Cardo,et al.  A multigenic program mediating breast cancer metastasis to bone. , 2003, Cancer cell.

[79]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[80]  E. Winer,et al.  Brain Metastases: The HER2 Paradigm , 2007, Clinical Cancer Research.

[81]  L. Mccauley,et al.  Skeletal metastasis: Established and emerging roles of parathyroid hormone related protein (PTHrP) , 2007, Cancer and Metastasis Reviews.

[82]  O. Nishimura,et al.  Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor , 2001, Nature.

[83]  N. Gebbia,et al.  Activin A circulating levels in patients with bone metastasis from breast or prostate cancer , 2006, Clinical & Experimental Metastasis.

[84]  F. Holstege,et al.  Dissection of a metastatic gene expression signature into distinct components , 2006, Genome Biology.

[85]  H. Clevers Wnt/beta-catenin signaling in development and disease. , 2006, Cell.

[86]  S Paget,et al.  THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST. , 1889 .

[87]  Y-j Liu,et al.  Full-length ADAMTS-1 and the ADAMTS-1 fragments display pro- and antimetastatic activity, respectively , 2006, Oncogene.

[88]  K. Pienta,et al.  Pathogenesis and treatment of prostate cancer bone metastases: targeting the lethal phenotype. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[89]  A. Tumber,et al.  Breast cancer cells induce osteoclast formation by stimulating host IL‐11 production and downregulating granulocyte/macrophage colony‐stimulating factor , 2004, International journal of cancer.

[90]  T. L. Drell,et al.  Effects of Neurotransmitters on the Chemokinesis and Chemotaxis of MDA-MB-468 Human Breast Carcinoma Cells , 2003, Breast Cancer Research and Treatment.

[91]  C. Bucana,et al.  Demonstration of multiple phenotypic diversity in a murine melanoma of recent origin. , 1981, Journal of the National Cancer Institute.

[92]  D. Kirsch,et al.  Survival after brain metastases from breast cancer in the trastuzumab era. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[93]  E. Abe Function of BMPs and BMP Antagonists in Adult Bone , 2006, Annals of the New York Academy of Sciences.

[94]  C. Logothetis,et al.  Osteoblasts in prostate cancer metastasis to bone , 2005, Nature Reviews Cancer.

[95]  M. Kattan,et al.  Preoperative plasma levels of transforming growth factor beta(1) (TGF-beta(1)) strongly predict progression in patients undergoing radical prostatectomy. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[96]  M. Noda,et al.  Endothelin modulates osteopontin and osteocalcin messenger ribonucleic acid expression in rat osteoblastic osteosarcoma cells , 1993, Journal of cellular biochemistry.

[97]  S. Aaronson,et al.  Prostate cancer cells promote osteoblastic bone metastases through Wnts. , 2005, Cancer research.

[98]  Charles Cha,et al.  Liver resection for metastatic colorectal cancer in the age of neoadjuvant chemotherapy and bevacizumab. , 2006, Clinical colorectal cancer.

[99]  I. Fidler,et al.  Selection of successive tumour lines for metastasis. , 1973, Nature: New biology.

[100]  F. Holstege,et al.  Maintenance of head and neck tumor gene expression profiles upon lymph node metastasis. , 2006, Cancer research.

[101]  K. Shitara,et al.  Blockade of Paracrine Supply of Insulin-Like Growth Factors Using Neutralizing Antibodies Suppresses the Liver Metastasis of Human Colorectal Cancers , 2005, Clinical Cancer Research.

[102]  I. Fidler,et al.  Role of organ selectivity in the determination of metastatic patterns of B16 melanoma. , 1980, Cancer research.

[103]  Michael A. Choti,et al.  A Phosphatase Associated with Metastasis of Colorectal Cancer , 2001, Science.

[104]  G. Stein,et al.  Fidelity of Runx2 Activity in Breast Cancer Cells Is Required for the Generation of Metastases-Associated Osteolytic Disease , 2004, Cancer Research.

[105]  Yi Lu,et al.  Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bone metastases through a dual mechanism. , 2005, Cancer research.

[106]  H. Mehdorn,et al.  Reduced metastasis-suppressor gene mRNA-expression in breast cancer brain metastases , 2005, Journal of Cancer Research and Clinical Oncology.

[107]  A. Mizokami,et al.  Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone. , 2001, The Journal of clinical investigation.

[108]  I. Asahina,et al.  Human osteogenic protein-1 induces chondroblastic, osteoblastic, and/or adipocytic differentiation of clonal murine target cells. , 1996, Experimental cell research.

[109]  I. Holen,et al.  Osteoprotegerin (OPG) Produced by Bone Marrow Stromal Cells Protects Breast Cancer Cells from TRAIL-Induced Apoptosis , 2004, Breast Cancer Research and Treatment.

[110]  Suyun Huang Regulation of Metastases by Signal Transducer and Activator of Transcription 3 Signaling Pathway: Clinical Implications , 2007, Clinical Cancer Research.

[111]  K. Aldape,et al.  Activation of stat3 in human melanoma promotes brain metastasis. , 2006, Cancer research.

[112]  Sunil Singhal,et al.  Gene expression signature predicts lymphatic metastasis in squamous cell carcinoma of the oral cavity , 2005, Oncogene.

[113]  L. Suva,et al.  Heparanase promotes the spontaneous metastasis of myeloma cells to bone. , 2004, Blood.